Several studies have associated increased PTH concentrations with adverse health outcomes, particularly musculoskeletal issues [10,25,26,27], since secondary hyperparathyroidism is associated with increased bone turnover rates and consequently increased bone loss [25,28]. The gene discussed is PTH; the disease is secondary hyperparathyroidism.